Selective inhibition by a class III antiarrhythmic agent, E-4031, of the negative chronotropic response to parasympathetic stimulation in anesthetized dogs

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 2, 1996, Pages 467-472

  Imamura, Hiroshi ^a   Furukawa, Yasuyuki ^a   Nakano, Hirofumi ^a   Kasama, Miho ^a   Hoyano, Yuji ^a   Chiba, Shigetoshi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; ANTIARRHYTHMIC AGENT; ARGIPRESSIN; PIPERIDINE DERIVATIVE; PYRIDINE DERIVATIVE;

ANIMAL; ARTICLE; CHEMICAL PHENOMENA; DOG; DRUG EFFECT; FEMALE; HEART CONTRACTION; HEART MUSCLE CONDUCTION SYSTEM; MALE; PHYSIOLOGY; VAGUS NERVE;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARGININE VASOPRESSIN; DEPRESSION, CHEMICAL; DOGS; FEMALE; HEART CONDUCTION SYSTEM; MALE; MYOCARDIAL CONTRACTION; PIPERIDINES; PYRIDINES; VAGUS NERVE;

EID: 0030087726     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. AKAHANE, K., FURUKAWA, Y., KARASAWA, Y. AND CHIBA, S.: Muscarinic receptor subtypes mediating negative chrono- and inotropic responses in isolated, blood-perfused dog right atria. J. Auton. Pharmacol. 10: 39-48, 1990.
2. ARDELL, J. L. AND RANDALL, W. C.: Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart. Am. J. Physiol. 251: H764-H773, 1986.
3. BIGGER, J. T., JR. AND FLEISS, J. L.. Methods for assessment of vagal tone and reflexes: Time domain measures. In Vagal Control of the Heart: Experimental Basis and Clinical Implications, ed by M. N. Levy and P. J. Schwartz, pp. 419-432, Futura Publishing Co. Inc., Armonk, NY, 1994.
4. BIGGER, J. T. AND SCHWARTZ, P. J.: Markers of vagal activity and the prediction of cardiac death after myocardial infarction. In Vagal Control of the Heart: Experimental Basis and Clinical Implications, ed by M. N. Levy and P. J. Schwartz, pp. 481-508, Futura Publishing Co. Inc., Armonk, NY, 1994.
5. BIRKHEAD, J. S AND VAUGHAN WILLIAMS, E. M.: Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods. Br Heart J 39: 657-660, 1977
6. CAMPBELL, D. L , RASMUSSON, R. L. AND STRAUSS, H. C., Ionic current pacemaker mechanisms generating vertebrate primary cardiac pacemaker activity at the single cell level: an integrative view. Annu. Rev. Physiol. 54: 279-302, 1992.
7. DIFRAMCESCO, D., DUCOURET, P. AND ROBINSON, R. B.: Muscarinic modulation of cardiac rate at low acetylcholine concentrations. Science 243:669-671, 1989.
8. f. Pflügers. Arch. 410: 139-142, 1987.
9. f) induced by acetylcholine in rabbit sino-atrial node myocytes. J. Physiol. 405: 477-491, 1988.
10. FURUKAWA, Y., WALLICK, D. W., CARLSON, M. D. AND MARTIN, P. J.: Cardiac electrical responses to vagal stimulation of fibers to discrete cardiac regions. Am. J. Physiol. 258: H1112-H1118, 1990.
11. FURUKAWA, Y., WALLICK, D. W. AND MARTIN, P.: Differential blocking effects of atropine and gallamine on negative chronotropic and dromotropic responses to vagus stimulation in anesthetized dogs. J. Pharmacol. Exp. Ther. 251: 797-802, 1989.
12. HUTTER, O. F. AND TRAUTWEIN, W.: Vagal and sympathetic effects on the pacemaker fibers in the sinus venosus of the heart. J. Gen. Physiol. 39: 715-732, 1956.
13. INOUE, Y., FURUKAWA, Y., NAKANO, H., SAWAKI, S, OGUCHI, T. AND CHIBA, S.: Parasympathetic control of right atrial pressure in anesthetized dogs. Am. J. Physiol. 266: H861-H866, 1994.
14. IRISAWA, H., BROWN, H. F. AND GILES, W.: Cardiac pacemaking in the sinoatrial node. Physiol. Rev. 73: 197-227, 1993.
15. KATOH, H., NOMOTO, K., SAWADA, K. AND SHOJI, T.: Electrophysiologic, antiarrhythmic and hemodynamic effects of E-4031, a novel class III antiarrhythmie agent in intact and infarcted dogs. Eur. Heart. J. 9: suppl., 232, 1988.
16. KATOH, H., OGAWA, S., FURUNO, I., SATO, Y., YOH, S., SAEKI, K. AND NAKAMURA, Y.: Electrophysiologic effects of E-4031, a class III antiarrhythmic agent, on re-entrant ventricular arrhythmias in a canine 7-day-old myocardial infarction model. J. Pharmacol. Exp. Ther. 253: 1077-1082, 1990.
17. KOCH-WESER, J. AND BLINKS, J. R.: The influence of the interval between beats on myocardial contractility. Pharmacol. Rev. 15: 601-652, 1963.
18. LEVY, M. N. AND MARTIN, P. J.: Neural control of the heart. In Handbook of Physiology: Section 2, The Cardiovascular System, vol. I, The Heart, ed. by R. M. Berne and N. Sperelakis, pp. 581-620, American Physiological Society, Bethesda, MD, 1979.
19. LEVY, M. N., NG, M. L. AND ZIESKE, H.: Functional distribution of the peripheral cardiac sympathetic pathways. Circ. Res. 19: 650-661, 1966.
20. LEVY, M. N. AND SCHWARTZ, P. J.: Vagal Control of the Heart: Experimental Basis and Clinical Implications, Futura Publishing Co. Inc., Armons, NY, 1994.
21. MIRRO, M. J., MANALAN, A. S., BAILEY, J. C. AND WATANABE, A. M.: Anticholinergic effects of disopyramide and quinidine on guinea pig myocardium: Mediation by direct muscarinic receptor blockade. Circ. Res. 47: 855-865, 1980a.
22. MIRRO, M. J., WATANABE, A. M. AND BAILEY, J. C.: Electrophysiological effects of disopyramide and quinidine on guinea pig atria and canine cardiac Purkinje fibers: Dependence on underlying cholinergic tone. Circ. Res. 46: 660-668, 1980b.
23. MOKLER, C. M. AND VAN ARMAN, C. G.: Pharmacology of a new antiarrhythmic agent, g-diisopropylamino-a-phenyl-a-(2-pyridyl)-butyramide (SC-7031). J. Pharmacol. Exp. Ther. 136: 114-124, 1962.
24. NAKAJIMA, T., KURACHI, Y., ITO, H., TAKIKAWA, R. AND SUGIMOTO, T.: Anticholinergic effects of quinidine, disopyramide, and procainamide in isolated atrial myocytes: Mediation by different molecular mechanisms. Circ. Res. 64: 297-303, 1989.
25. 1 receptor subtype on chrono-tropic and dromotropic responses to vagus stimulation in anesthetized dogs. J. Pharmacol. Exp. Ther. 258: 166-170, 1991.
26. + current. Circulation 82: suppl., III-527, 1990.
27. + channels in isolated pacemaker cells of the mammalian heart. Nature 303: 250-253, 1983.
28. + current: Differential sensitivity to block by class III antiarrhythmic agents. J. Gen. Physiol. 96: 195-215, 1990.
29. + current is composed of two currents in guinea pig atrial cells. Am. J. Physiol. 260: H393-H399, 1991.
30. SAWADA, K.: Depression of the delayed outward K current by novel class III antiarrhythmic agent, E-4031, in guinea pig single ventricular cells. J. Mol. Cell. Cardiol. 21: supple II, S20, 1989.
31. SAWADA, K., NOMOTO, K. AND HIRAOKA, M : Effects of a novel class 3 antiarrhythmic agent, E-4031, on ventricular arrhythmias. Jpn. Circ. J. 52: suppl., 919, 1988.
32. WALLACE, A. A., STUPIESSKI, R. F., BROOKES, L. M., SELNICK, H G., CLAREMON, D. A. AND LYNCH, J. J., JR.: Cardiac electrophysiologic and inotropic actions of new and potent methanesulfonanilide class III antiarrhythmic agents in anesthetized dogs. J. Cardiovasc. Pharmacol. 18: 687-695, 1991.
33. WETTWER, E., SCHOLTYSIK, G., SCHAAD, A., HIMMEL, H. AND RAVENS, U.: Effects of the new class III antiarrhythmic drug E-4031 on myocardial contractility and electrophysiological parameters. J. Cardiovasc Pharmacol. 17: 480-487, 1991.